Loss of the oncogenic phosphatase PRL-3 promotes a TNF-R1 feedback loop that mediates triple-negative breast cancer growth.
about
Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesionKnockdown of PRL-3 increases mitochondrial superoxide anion production through transcriptional regulation of RAP1
P2860
Loss of the oncogenic phosphatase PRL-3 promotes a TNF-R1 feedback loop that mediates triple-negative breast cancer growth.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@en
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@nl
type
label
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@en
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@nl
prefLabel
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@en
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@nl
P2093
P2860
P356
P1433
P1476
Loss of the oncogenic phosphat ...... negative breast cancer growth.
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2016.50
P577
2016-08-15T00:00:00Z